Search Results

Filter
  • 1-10 of  1,007 results for ""ANTINEOPLASTIC agents""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Editorial & Opinion

Unmet needs in relapsed/refractory mantle cell lymphoma after failure of covalent Bruton's tyrosine kinase inhibitors: An Italian scenario.

  • Authors : Pinto A; Department of Hematology and Developmental Therapeutics, Istituto Nazionale Tumori, Fondazione 'G. Pascale', IRCCS, Naples, Italy.; Ladetto M

Subjects: Lymphoma, Mantle-Cell*/Lymphoma, Mantle-Cell*/Lymphoma, Mantle-Cell*/drug therapy ; Lymphoma, Mantle-Cell*/Lymphoma, Mantle-Cell*/Lymphoma, Mantle-Cell*/pathology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use

  • Source: Hematological oncology [Hematol Oncol] 2024 Jan; Vol. 42 (1), pp. e3246.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print Cited Medium: Internet ISSN: 1099-1069

Record details

×
Academic Journal

Access and use of WHO essential medicines in Italy.

Subjects: Antineoplastic Agents* ; Drugs, Essential*/Drugs, Essential*/Drugs, Essential*/therapeutic use; World Health Organization

  • Source: Frontiers in public health [Front Public Health] 2023 Oct 10; Vol. 11, pp. 1211208. Date of Electronic Publication: 2023 Oct 10 (Print Publication: 2023).Publisher: Frontiers Editorial Office Country of Publication: Switzerland NLM ID: 101616579 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Incidence of SARS-CoV-2 Infection Among Patients Undergoing Active Antitumor Treatment in Italy.

  • Authors : Aschele C; Medical Oncology Unit, Department of Oncology, Ospedale Sant'Andrea, La Spezia, Italy.; Negru ME

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; COVID-19/COVID-19/COVID-19/*epidemiology ; Neoplasms/Neoplasms/Neoplasms/*drug therapy

  • Source: JAMA oncology [JAMA Oncol] 2021 Feb 01; Vol. 7 (2), pp. 304-306.Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology.

  • Authors : Pascarella G; Scientific Directorate, Istituto Nazionale Tumori 'Fondazione G. Pascale', IRCCS, Napoli, Italy.; Capasso A

Subjects: Health Care Costs*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*economics ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use

  • Source: PloS one [PLoS One] 2019 Jan 08; Vol. 14 (1), pp. e0210330. Date of Electronic Publication: 2019 Jan 08 (Print Publication: 2019).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group.

  • Authors : Franzese C; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090, Pieve Emanuele-Milan, Italy. .; Radiotherapy and Radiosurgery Department., IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano, MI, Italy. .

Subjects: Radiosurgery*/Radiosurgery*/Radiosurgery*/adverse effects ; Radiosurgery*/Radiosurgery*/Radiosurgery*/mortality; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use

  • Source: Clinical & experimental metastasis [Clin Exp Metastasis] 2021 Dec; Vol. 38 (6), pp. 527-537. Date of Electronic Publication: 2021 Nov 08.Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 8409970 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma.

  • Authors : Bulgarelli J; Immunotherapy, Cell Therapy and Biobank Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Piccinini C

Subjects: Chemoradiotherapy*/Chemoradiotherapy*/Chemoradiotherapy*/adverse effects; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*administration & dosage ; Carcinoma, Renal Cell/Carcinoma, Renal Cell/Carcinoma, Renal Cell/*therapy

  • Source: Frontiers in immunology [Front Immunol] 2021 Oct 27; Vol. 12, pp. 778459. Date of Electronic Publication: 2021 Oct 27 (Print Publication: 2021).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial.

Subjects: Mastectomy* ; Postmenopause*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*administration & dosage

  • Source: The Lancet. Oncology [Lancet Oncol] 2021 Oct; Vol. 22 (10), pp. 1458-1467. Date of Electronic Publication: 2021 Sep 17.Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Skip pattern approach toward the early access of innovative anticancer drugs.

  • Authors : Apolone G; Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.; Ardizzoni A

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy; Government Agencies

  • Source: ESMO open [ESMO Open] 2021 Aug; Vol. 6 (4), pp. 100227. Date of Electronic Publication: 2021 Aug 02.Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029

Record details

×
Academic Journal

Immune-checkpoint inhibition in stage III unresectable NSCLC: Challenges and opportunities in the post-PACIFIC era.

  • Authors : Passiglia F; Department of Oncology, University of Turin, S. Luigi Gonzaga Hospital, Orbassano (TO), Italy. Electronic address: .; Leone G

Subjects: Antineoplastic Agents, Immunological*/Antineoplastic Agents, Immunological*/Antineoplastic Agents, Immunological*/therapeutic use ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/drug therapy; Chemoradiotherapy

  • Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2021 Jul; Vol. 157, pp. 85-91. Date of Electronic Publication: 2021 May 11.Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
  • 1-10 of  1,007 results for ""ANTINEOPLASTIC agents""